Physician profile
Alan D Noel
NPI 1770517617
$2,445.09
in general payments reported to CMS, 2019-2025
29 companies · $499 in 2025
The $499 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $435 · 2020: $143 · 2022: $287 · 2023: $483 · 2024: $598 · 2025: $499.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,535 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,535.04 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $269.34 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Novo Nordisk INC | $262.28 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Supernus Pharmaceuticals, INC. | $233.79 | 2019-2020 | |
| Pfizer INC. | $195.36 | 2019-2025 | |
| Lilly USA, LLC | $171.46 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $141.82 | 2019-2025 | Jardiance, Stiolto Respimat |
| Merck Sharp & Dohme LLC | $124.38 | 2019-2025 | Verquvo, Capvaxive, Gardasil 9 |
| Abbvie INC. | $103.82 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $97.12 | 2023-2025 | |
| Amgen INC. | $80.49 | 2019-2024 | Prolia, Evenity, Otezla |
| Exact Sciences Corporation | $79.07 | 2023-2025 | Cologuard Collection Kit |
| Abbott Laboratories | $79.04 | 2022-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Glaxosmithkline, LLC. | $78.27 | 2022-2025 | Arexvy, Shingrix |
| Dexcom, INC. | $67.93 | 2023-2025 | Dexcom G6 Transmitter |
| Dynavax Technologies Corporation | $59.72 | 2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $57.62 | 2024-2025 | Voquezna |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $51.94 | 2023-2025 | Xifaxan, Trulance |
| Janssen Pharmaceuticals, INC | $48.74 | 2022-2024 | Xarelto |
| Inspire Medical Systems, INC. | $41.23 | 2024 | Inspire |
| Sanofi-Aventis U.S. LLC | $33.55 | 2020-2023 | |
| Mylan Specialty L.P. | $27.23 | 2023-2024 | Yupelri |
| Alkermes, INC. | $24.64 | 2024 | Vivitrol |
| Lucid Diagnostics INC. | $19.06 | 2023 | |
| Viatris Specialty LLC | $18.36 | 2025 | Yupelri |
| Biohaven Pharmaceutical Holding Company LTD. | $18.33 | 2022 | |
| Astellas Pharma US INC | $17.31 | 2024 | Veozah |
| Novartis Pharmaceuticals Corporation | $15.95 | 2023 | |
| Lundbeck LLC | $13.99 | 2025 | Rexulti |
| Kowa Pharmaceuticals America, INC. | $13.25 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Noel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.